Skip to content

Impacts of a Physician-targeted Price Transparency Tool on Medication Out-of-pocket Costs

Impacts of a Physician-targeted Price Transparency Real Time Prescription Benefits Tool on Medication Out-of-pocket Costs

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04940988
Enrollment
21401
Registered
2021-06-28
Start date
2020-11-18
Completion date
2021-07-30
Last updated
2021-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Costs and Cost Analysis, Prescriptions

Brief summary

The goal of this study is to evaluate whether presenting patient out-of-pocket cost information to the provider at the time of prescribing leads to orders for medications with lower out-of-pocket costs. The Real-Time Prescription Benefits (RTPB) tool has been implemented to randomly selected providers across NYU Langone Health's outpatient physician practices. The RTPB tool provides physicians with information about patient out-of-pocket (OOP) cost for medications at the point of outpatient prescribing. OOP is inclusive of any copay, coinsurance, and deductible that the patient owes given their prescription drug benefit plan. If the physician is submitting a prescription order and a clinically-appropriate alternative with a lower OOP cost is available, an alert with OOP cost information for the drug being initially ordered as well as up to three lower-cost alternatives will be displayed. Implementation of this tool will be analyzed to see if it will lead to reduced out-of-pocket costs on ordered medications when alternatives were available. Because effects could vary along many dimensions (e.g., specialty, drug class, insurance type), secondary analyses will be conducted and stratified along such dimensions. Analyses will be conducted at the prescription order level.

Interventions

OTHERReal-time benefits check

Prescribers practicing in outpatient departments assigned to the intervention arm will be shown popup alerts with their patient's insurance benefit design-specific out-of-pocket cost for the drug being ordered as well as out-of-pocket costs for up to 3 lower-cost alternatives if available. Alternatives will only be shown when available and when the patient and his or her benefit design information can be matched by the electronic health record system to accurately query out-of-pocket cost information.

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* Medication orders for which this match and query was successful and outcomes data was available.

Exclusion criteria

* No patient-level

Design outcomes

Primary

MeasureTime frameDescription
Medication out of pocket cost per dayThrough study completion, an average of 1 yearThe primary outcome, which will be measured at the medication-order level is out-of-pocket cost per day for a drug ordered. It will be computed by dividing the out-of-pocket cost of a drug by the days supply. Data will be collected through the electronic health record.

Secondary

MeasureTime frameDescription
Whether an order was placed for a mail-order pharmacyThrough study completion, an average of 1 yearA secondary outcome, also specified at the order level, is whether a drug prescription was ordered from a mail-order pharmacy, since switching to a mail-order pharmacy often presents an opportunity for savings. Data will be collected through the electronic health record.
Days supplyThrough study completion, an average of 1 yearA secondary outcome, also specified at the order level, is the days supply. Data will be collected through the electronic health record.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 16, 2026